SCHEMBL25474174

SCHEMBL25474174

CN[C@@H]1CC2CC[C@H](C1)N2C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
CYP2C9 P11712 1/20 0.50
SLC6A2 P23975 5/20 0.43
CHRM1 P11229 4/20 0.43
SLC6A4 P31645 4/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
HRH1 P35367 1/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA4 P43681 1/20 0.37
HTR3A P46098 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
HTR3D Q70Z44 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18502846 1.00 LMNA (0.50) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL1573740 1.00 LMNA (0.50) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL1573739 1.00 LMNA (0.50) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL3582332 0.90 HTR3E (0.46) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL9381779 0.90 HTR3E (0.46) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL13778750 0.86 LMNA (0.40) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL15444631 0.80 HTR3A (0.34) LMNACYP2C9HTR3A
SCHEMBL20715143 0.80 LMNA (0.46) LMNACYP2C9SLC6A2CHRM1SLC6A4
SCHEMBL3408333 0.79 MEN1 (0.38) MEN1KMT2A
SCHEMBL3411137 0.78 HTR4 (0.31) LMNACYP2C9HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733663-B1 1-[6-[[4-(PHENYLAMINO)-6-QUINAZOLINYL]OXY]-3-AZABICYCLO[3.1.1]HEPT-3-YL]-2-PROPEN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS IRREVERSIBLE INHIBITORS OF PAN-HER TYROSINE KINASE FOR THE TREATMENT OF CANCER CHENGDU JINRUI FOUND BIOTECH CO LTD (CN) 2023-05-17 EP disclosed